NPCE NeuroPace, Inc.
Healthcare$16.92+3.93%ClosedMarket Cap: $576.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$21.00
Target (Median)
$21.00
Target Range
$20.00 - $22.00
Upside from current price: 24.1%
Rating Distribution
1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-16 | UBS | maintain | Buy | Buy |
| 2025-12-10 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-05 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-05 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-08-13 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.30 | $123.3M | 6 |
| Sun Dec 31 | $-0.09 | $153.4M | 5 |
| Mon Dec 31 | $0.38 | $187.4M | 1 |
| Tue Dec 31 | $0.36 | $213.4M | 1 |